bpc-157 fda warning august 2025 On 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Big FDA review coming this

Several peptides have been studied for their potential anti-inflammatory properties, including BPC-157, TB-500, KPV, and GHK-Cu

Compared to injectable peptides, this oral bioavailability offers a practical and non-invasive mode of delivery, which is a major benefit

Multi-Dose 30mL Vial Convenient 30mL format designed for repeated research-use applications

Suitability should be assessed by an appropriately qualified healthcare professional.

36,286,332 In addition to participating in inflammatory responses, microglia and astrocytes also play key roles in maintaining brain homoeostasis by regulating synaptic morphology and plasticity

Some people may experience mild soreness at the injection site